Mutations of BRCA genes in hereditary breast and ovarian cancer

Journal of Experimental and Clinical Cancer Research

Volumn 21, Issue 3 SUPPL., 2002, Pages 9-12

  Radice, P ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

BRCA1; BRCA2; Breast carcinoma; Hereditary cancer; Mutation; Ovarian carcinoma

Indexed keywords

BREAST CARCINOMA; CANCER RISK; CANCER SUSCEPTIBILITY; CONFERENCE PAPER; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA DETERMINATION; DNA SEQUENCE; FAMILIAL CANCER; GENE DELETION; GENE FUNCTION; GENE MUTATION; GENE STRUCTURE; GENETIC PREDISPOSITION; GENETIC TRANSCRIPTION; HETEROZYGOTE; HUMAN; MOLECULAR GENETICS; ONCOGENE; OVARY CARCINOMA; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE STRAND CONFORMATION POLYMORPHISM;

BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC SCREENING; HUMANS; MUTATION; OVARIAN NEOPLASMS;

EID: 0036767376     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (42)

1. Miki Y., Swensen J., Shattuck-Eidens D., et al.: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71, 1994.
2. Wooster R., Bignell G., Lancaster J., et al.: Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789- 792, 1995.
3. Tavtigian S.V., Simard J., Rommens J., et al.: The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat. Genet. 12: 333-337, 1996.
4. Narod S.A., Ford D., Devilee P., et al.: An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium. Am. J. Hum. Genet. 56:254-264, 1995.
5. Ford D., Easton D.F., Stratton M., et al.: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am. J. Hum. Genet. 62: 676-689, 1998.
6. Bishop D.T.: BRCA1 and BRCA2 and breast cancer incidence: a review. Ann. Oncol. 10 (Suppl 6): S 113-S119, 1999.
7. Nathanson K.L., Weber B.L.: "Other" breast cancer susceptibility genes: searching for more holy grail. Hum. Mol. Genet. 10: 715-720, 2001.
8. Hall J.M., Lee M.K., Newman B., Morrow J.E., Anderson L.A., Huey B., King M.C.: Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250: 1684-1689, 1990.
9. Chapman M.S., Verma I.M.: Transcriptional activation by BRCA1. Nature 382: 678-679, 1996.
10. Wooster R., Neuhausen S.L., Mangion J., et al.: Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265: 2088-2090, 1994.
11. Scully R, Livingston DM. In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408: 429-432, 2000.
12. Zheng L., Li S., Boyer T.G., Lee W.H.: Lessons learned from BRCA1 and BRCA2. Oncogene 19: 6159-6175, 2000.
13. Kerr P., Ashworth A.: New complexities for BRCA1 and BRCA2. Curr. Biol. 11: R668-R676, 2001.
14. Venkitaraman A.R.: Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108:171-182, 2002.
15. Petrij-Bosch A., Peelen T., van Vliet M., et al.: BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat. Genet. 17: 341-345, 1997.
16. Puget N., Stoppa-Lyonnet D., Sinilnikova O.M., et al.: Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions. Cancer Res. 59: 455-461, 1999.
17. Wang T., Lerer I., Gueta Z., et al.: A deletion/insertion mutation in the BRCA2 gene in a breast cancer family: a possible role of the Alu-poly A tail in the evolution of the deletion. Genes Chromosomes Cancer 31: 91-95, 2001.
18. Szabo C.I., King M.C.: Population genetics of BRCA1 and BRCA2. Am. J. Hum. Genet. 60: 1013-1020, 1977.
19. Thorlacius S., Olafsdottir G., Tryggvadottir L., et al.: A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat. Genet. 13: 117-119, 1996.
20. Tonin P., Weber B., Offit K., et al.: Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat. Med. 2: 1179-1183, 1996.
21. Caligo M.A., Ghimenti C., Cipollini G., et al.: BRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutations. Oncogene 13: 1483-1488, 1996.
22. Pisano M., Cossu A., Persico I., et al.: Identification of a founder BRCA2 mutation in Sardinia. Br. J. Cancer 82: 553-559, 2000
23. Baudi F., Quaresima B., Grandinetti C., et al.: Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer. Hum. Mutat. 18: 163-164, 2001.
24. De Benedetti V.M., Radice P., Mondini P., et al.: Screening for mutations in exon 11 of the BRCA1 gene in 70 Italian breast and ovarian cancer patients by protein truncation test. Oncogene 13: 1353-1357, 1996.
25. De Benedetti V.M., Radice P., Pasini B., et al.: Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Mutations in brief no. 178. Online. Hum. Mutat. 12: 215, 1998.
26. Grompe M.: The rapid detection of unknown mutations in nucleic acids. Nat. Genet. 5: 111-117, 1993.
27. Eng C., Brody L.C., Wagner T.M., et al.: Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1. J. Med. Genet. 38: 824-833, 2001.
28. Ricevuto E., Sobol H., Stoppa-Lyonnet D., et al.: Diagnostic strategy for analytical scanning of BRCA1 gene by fluorescence-assisted mismatch analysis using large, bifluorescently labeled amplicons. Clin Cancer Res 7: 1638-1646, 2001.
29. Payne S.R., Newman B., King M.C.: Complex germline rearrangement of BRCA1 associated with breast and ovarian cancer. Genes Chromosomes Cancer 29: 58-62, 2000.
30. Robinson M.D., Chu C.E., Turner G., Bishop D.T., Taylor G.R.: Exon deletions and duplications in BRCA1 detected by semiquantitative PCR. Genet. Test. 4: 49-54, 2000.
31. Gad S., Aurias A., Puget N., et al.: Color bar coding the BRCA1 gene on combed DNA: a useful strategy for detecting large gene rearrangements. Genes Chromosomes Cancer 31: 75-84, 2001.
32. Yan H., Papadopoulos N., Marra G;, et al.: Conversion of diploidy to haploidy. Nature 403:723-724, 2000.
33. Brzovic P.S., Meza J., King M.C., Klevit R.E.: The cancer-predisposing mutation C61G disrupts homodimer formation in the NH2-terminal BRCA1 RING finger domain. J. Biol. Chem. 273: 7795-7799, 1998.
34. Humphrey J.S., Salim A., Erdos M.R, Collins F.S., Brody L.C., Klausner R.D.: Human BRCA1 inhibits growth in yeast: potential use in diagnostic testing. Proc. Natl. Acad. Sci. U.S.A. 94: 5820-5825, 1977.
35. Vallon-Christersson J., Cayanan C., Haraldsson K., et al.: Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families. Hum. Mol. Genet. 10: 353-360, 2001.
36. Nathanson K.N., Wooster R., Weber B.L.: Breast cancer genetics: what we know and what we need. Nat. Med. 7: 552-556, 2001.
37. Ponder B.A.: Cancer genetics. Nature 411: 336-341, 2001.
38. Tillib S.V., Mirzabekov A.D.: Advances in the analysis of DNA sequence variations using oligonucleotide microchip technology. Curr. Opin. Biotechnol. 12: 53-58, 2001.
39. Couch F.J., DeShano M.L., Blackwood M.A., et al.: BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N. Engl. J. Med. 336: 1409-1415, 1997.
40. Frank T.S., Manley S.A., Olopade O.I., et al.: Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J. Clin. Oncol. 16: 2417-2425, 1998.
41. Berry D.A., Parmigiani G., Sanchez J., Schildkraut J., Winer E.: Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J. Natl. Cancer Inst. 89: 227-238, 1997.
42. Parmigiani G., Berry D., Aguilar O.: Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am. J. Hum. Genet. 62: 145-158, 1998.